Clinical Trials
6 trialsNCT03357224 2024-02-22
PARCT
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT04218825 2023-11-09
REACH
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT00057954 2023-06-28
Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma
Eastern Cooperative Oncology Group
Phase 2 Terminated
NCT03563040 2021-09-08
PROMPT
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Withdrawn
NCT00074087 2018-07-09
Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00110045 2012-09-24
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed